Company Veloxis Pharmaceuticals A/S

VELO

DK0060048148

Pharmaceuticals

Delayed Nasdaq Copenhagen Other stock markets			5-day change	1st Jan Change
- ^DKK	-.--%		-.--%	-0.50%

2024	Veloxis Pharmaceuticals A/S Selects to Present At the 2024 American Transplant Congress in Philadelphia	CI
2022	Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)	CI

Business description: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S is a Denmark-based commercial-stage specialty pharmaceutical Company. The Companyâs product Envarsus XR (tacrolimus extended-release tablets) is a prescription medicine used with other medicines to help prevent organ rejection in people who have had a kidney transplant. It is based upon the Companyâs patented delivery technology, MeltDose, which is designed to enhance the absorption and bioavailability of select orally administered drugs. The Company operates in the United States through its subsidiary, Veloxis Pharmaceuticals Inc.

Sales by Activity: Veloxis Pharmaceuticals A/S

Fiscal Period: December	2018
Specialty Pharmaceutical	39.49M

See all business segments

Geographical breakdown of sales: Veloxis Pharmaceuticals A/S

Fiscal Period: December	2018
Denmark	39.49M

See all geographic segments

Executive Committee: Veloxis Pharmaceuticals A/S

Manager	Title	Age	Since
Daisuke Matsuo ADM	Chief Administrative Officer	-	-
Ulf Meier-Kriesche CTO	Chief Tech/Sci/R&D Officer	-	2017-09-12
Stacy Wheeler COO	Chief Operating Officer	-	2016-02-29
Noel Barnard LAW	General Counsel	-	2016-02-29
Rita L. Mannella HRO	Human Resources Officer	-	2016-12-31

See VELOXIS PHARMACEUTICALS A/S governance

Composition of the Board of Directors: Veloxis Pharmaceuticals A/S

Director	Title	Age	Since
Daisuke Matsuo BRD	Director/Board Member	-	-

Composition of the Board of Directors

Company details: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S

Gdanskgade 18 Nordhavn

2150, Copenhagen

http://www.veloxis.com

address Veloxis Pharmaceuticals A/S(VELO)

Group companies: Veloxis Pharmaceuticals A/S

Name	Category and Sector
Veloxis Pharmaceuticals, Inc. Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The company is based in Edison, NJ.	Pharmaceuticals: Major

See all subsidiaries

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
VELOXIS PHARMACEUTICALS A/S	-.--%	-.--%	-	-	1.64B
MERCK KGAA	-1.42%	-0.35%	-33.37%	-31.50%	57.7B
KYOWA KIRIN CO., LTD.	0.00%	+2.28%	-7.32%	-12.65%	9.05B
HALOZYME THERAPEUTICS, INC.	-1.03%	-0.50%	+8.79%	+25.24%	6.65B
YUHAN CORPORATION	-1.75%	+2.60%	+42.57%	+110.80%	5.82B
SK BIOPHARMACEUTICALS CO., LTD.	-3.42%	-0.11%	+13.58%	+18.19%	5.18B
BETTA PHARMACEUTICALS CO., LTD.	-1.97%	+1.33%	+65.31%	+26.41%	3.71B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	-1.55%	+0.74%	+0.19%	+20.74%	2.02B
SUPERNUS PHARMACEUTICALS, INC.	-2.26%	-3.38%	+20.59%	+20.82%	1.79B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-3.26%	-5.29%	-63.07%	-8.49%	1.75B
Average	-1.67%	-1.17%	+5.25%	+18.84%	9.53B
Weighted average by Cap.	-1.44%	-0.28%	-15.43%	-9.21%